NEW YORK, Sept. 19, 2016
NEW YORK, Sept. 19, 2016 /PRNewswire/ --
Future Market Insights (FMI) offers a 10-year forecast of the India coronary stents market between 2016 and 2026. In terms of value, the market is expected to register a CAGR of 14.0% over the forecast period. This study demonstrates market dynamics and trends that influence the current environment and future status of the coronary stents market in India over the forecast period.
This Future Market Insights report examines India coronary stents market for the period 2016–2026. The primary objective of the report is to offer insights on various coronary stents market products such as Drug eluting stent (DES), Bare Metal Stent (BMS) and Bioresorbable Vascular Stent (BVS).
This report begins by defining various coronary stents market product types and top brands in the market. It is followed by an overview of market dynamics of the India coronary stents market, which includes FMI analysis of key trends, drivers, restraints and opportunities and key players. It also includes insights into product highlighting regional trends and reimbursement scenario. Impact analyses of key growth drivers and restraints based on the weighted average model have also been included in the report to better equip readers with meaningful insights on ongoing developments in the market.
Primary factors fuelling growth of the global coronary stents market include rapidly ageing population with coronary heart disease indication, strong healthcare consciousness and modified coronary stents. Other factors driving demand for coronary stents market are rising number of PCI procedures and easy access to reimbursement.
Coronary stents products based on advanced technology helps in reducing restenosis after angioplasty. On the contrary, factors such as high cost of stents and regional competition among local players in India are factors expected to hamper market growth in the country in the near future.
Based on product type, the market has been segmented into Drug Eluting Stent, Bare Metal Stent & Bioresorbable Vascular Stent. A detailed analysis has been provided for every segment in terms of market size, Y-o-Y growth rate, absolute $ opportunity and BPS analysis.
Based on raw material type, the market has been segmented into Cobalt Chromium, Stainless Steel, Platinum Chromium, Nickel Titanium and Polymer. A detailed analysis has been provided for every segment in terms of market size, Y-o-Y growth rate, absolute $ opportunity and BPS analysis.
Furthermore, on the basis of end users, hospitals segment is expected to witness significant demand for coronary stents over the forecast period. This trend is expected to be particularly prominent in India, which are increasing access to healthcare services. However, Cardiac Catheterization Laboratories segment is expected to exhibit the highest growth over the forecast period.
The above sections—by product type, raw material and end users—evaluate the present scenario and growth prospects of the India coronary stents market for 2016–2026. We have considered 2015 as the base year and provided data for the forecast period.
In addition, it is imperative to note that in an ever-fluctuating developing economy, we not only conduct forecasts in terms of CAGR, but also provide analysis based on key parameters such as year-on-year (Y-o-Y) growth rates to understand the predictability of the market and to identify the right opportunities across the coronary stents market.
The coronary stents market in terms of product, raw material and end users are analyzed in terms of Basis Point Share (BPS) to understand individual segment's relative contributions to market growth. This detailed level of information is important for identifying various key trends in the coronary stents market.
Another key feature of this report is the analysis of key segments in terms of absolute dollar opportunity. This is traditionally overlooked while forecasting the market. However, absolute dollar opportunity is critical for assessing the level of opportunity that a provider can look to achieve, as well as to identify potential resources from a sales and delivery perspective of the coronary stents market.
In the final section of the report, competitive landscape of the coronary stents market is included to provide report audiences with a dashboard view, based on categories of providers in the value chain, their respective product portfolios and key differentiators. Key categories of providers covered in the report are coronary stents companies. This section is primarily designed to provide clients with an objective and detailed comparative assessment of key providers specific to a market segment in the coronary stents market value chain and potential players for the same. Report audiences can gain segment-specific vendor insights to identify and evaluate key competitors based on in-depth assessment of capabilities and successes in the coronary stents market.
Detailed profiles of the providers are also included in the scope of the report to evaluate their long-term and short-term strategies, key offerings, SWOT analysis and recent developments in the coronary stents market. Key manufacturers included in the report are Abbott Laboratories, Medtronic, Inc., Biosensors International Group Ltd. And Boston Scientific Inc.
Drug Eluting Stent
Bare Metal Stent
Bioresorbable Vascular Stent
Raw Material Type
Ambulatory Surgical Centres
Cardiac Catheterization Laboratories
Biosensors International Group Ltd.
Boston Scientific Inc.
Read the full report: http://www.reportlinker.com/p03884067-summary/view-report.html
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
Contact Clare: email@example.com
Intl: +1 339-368-6001
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/coronary-stents-market-india-industry-analysis-and-opportunity-assessment-2016-2026-300330571.html
SOURCE ReportlinkerPR Newswire
Last updated on: 20/09/2016
PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.